Literature DB >> 32533279

Negative synergism of diabetes mellitus and obesity in patients with heart failure with preserved ejection fraction: a cardiovascular magnetic resonance study.

Selcuk Kucukseymen1, Ulf Neisius1, Jennifer Rodriguez1, Connie W Tsao1, Reza Nezafat2.   

Abstract

In patients with heart failure with preserved ejection fraction (HFpEF), diabetes mellitus (DM) and obesity are important comorbidities as well as major risk factors. Their conjoint impact on the myocardium provides insight into the HFpEF aetiology. We sought to investigate the association between obesity, DM, and their combined effect on alterations in the myocardial tissue in HFpEF patients. One hundred and sixty-two HFpEF patients (55 ± 12 years, 95 men) and 45 healthy subjects (53 ± 12 years, 27 men) were included. Patients were classified according to comorbidity prevalence (36 obese patients without DM, 53 diabetic patients without obesity, and 73 patients with both). Myocardial remodeling, fibrosis, and longitudinal contractility were quantified with cardiovascular magnetic resonance imaging using cine and myocardial native T1 images. Patients with DM and obesity had impaired global longitudinal strain (GLS) and increased myocardial native T1 compared to patients with only one comorbidity (DM + Obesity vs. DM and Obesity; GLS, - 15 ± 2.1 vs - 16.5 ± 2.4 and - 16.7 ± 2.2%; native T1, 1162 ± 37 vs 1129 ± 25 and 1069 ± 29 ms; P < 0.0001 for all). A negative synergistic effect of combined obesity and DM prevalence was observed for native T1 (np2 = 0.273, p = 0.002) and GLS (np2 = 0.288, p < 0.0001). Additionally, severity of insulin resistance was associated with GLS (R = 0.590, P < 0.0001), and native T1 (R = 0.349, P < 0.0001). The conjoint effect of obesity and DM in HFpEF patients is associated with diffuse myocardial fibrosis and deterioration in GLS. The negative synergistic effects observed on the myocardium may be related to severity of insulin resistance.

Entities:  

Keywords:  Cardiovascular magnetic resonance; Diabetes mellitus; Heart failure with preserved ejection fraction; Myocardial fibrosis; Obesity

Mesh:

Year:  2020        PMID: 32533279     DOI: 10.1007/s10554-020-01915-4

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  42 in total

Review 1.  Heart Failure With Preserved Ejection Fraction and Diabetes: JACC State-of-the-Art Review.

Authors:  Kelly McHugh; Adam D DeVore; Jingjing Wu; Roland A Matsouaka; Gregg C Fonarow; Paul A Heidenreich; Clyde W Yancy; Jennifer B Green; Natasha Altman; Adrian F Hernandez
Journal:  J Am Coll Cardiol       Date:  2019-02-12       Impact factor: 24.094

2.  Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction.

Authors:  Masaru Obokata; Yogesh N V Reddy; Sorin V Pislaru; Vojtech Melenovsky; Barry A Borlaug
Journal:  Circulation       Date:  2017-04-05       Impact factor: 29.690

3.  Baseline characteristics of patients in the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial.

Authors:  Sanjiv J Shah; John F Heitner; Nancy K Sweitzer; Inder S Anand; Hae-Young Kim; Brian Harty; Robin Boineau; Nadine Clausell; Akshay S Desai; Rafael Diaz; Jerome L Fleg; Ivan Gordeev; Eldrin F Lewis; Valetin Markov; Eileen O'Meara; Bondo Kobulia; Tamaz Shaburishvili; Scott D Solomon; Bertram Pitt; Marc A Pfeffer; Rebecca Li
Journal:  Circ Heart Fail       Date:  2012-12-20       Impact factor: 8.790

4.  Cardiovascular phenotype in HFpEF patients with or without diabetes: a RELAX trial ancillary study.

Authors:  Brian R Lindman; Victor G Dávila-Román; Douglas L Mann; Steven McNulty; Marc J Semigran; Gregory D Lewis; Lisa de las Fuentes; Susan M Joseph; Justin Vader; Adrian F Hernandez; Margaret M Redfield
Journal:  J Am Coll Cardiol       Date:  2014-08-12       Impact factor: 24.094

5.  The Association of Obesity and Cardiometabolic Traits With Incident HFpEF and HFrEF.

Authors:  Nazir Savji; Wouter C Meijers; Traci M Bartz; Vijeta Bhambhani; Mary Cushman; Matthew Nayor; Jorge R Kizer; Amy Sarma; Michael J Blaha; Ron T Gansevoort; Julius M Gardin; Hans L Hillege; Fei Ji; Willem J Kop; Emily S Lau; Douglas S Lee; Ruslan Sadreyev; Wiek H van Gilst; Thomas J Wang; Markella V Zanni; Ramachandran S Vasan; Norrina B Allen; Bruce M Psaty; Pim van der Harst; Daniel Levy; Martin Larson; Sanjiv J Shah; Rudolf A de Boer; John S Gottdiener; Jennifer E Ho
Journal:  JACC Heart Fail       Date:  2018-07-11       Impact factor: 12.035

6.  Abdominal Obesity Is Associated With an Increased Risk of All-Cause Mortality in Patients With HFpEF.

Authors:  Tetsuro Tsujimoto; Hiroshi Kajio
Journal:  J Am Coll Cardiol       Date:  2017-12-05       Impact factor: 24.094

7.  Functional Status, Pulmonary Artery Pressure, and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.

Authors:  Daniel Dalos; Julia Mascherbauer; Caroline Zotter-Tufaro; Franz Duca; Andreas A Kammerlander; Stefan Aschauer; Diana Bonderman
Journal:  J Am Coll Cardiol       Date:  2016-07-12       Impact factor: 24.094

8.  Impact of Diabetes Mellitus on Ventricular Structure, Arterial Stiffness, and Pulsatile Hemodynamics in Heart Failure With Preserved Ejection Fraction.

Authors:  Julio A Chirinos; Priyanka Bhattacharya; Anupam Kumar; Elizabeth Proto; Prasad Konda; Patrick Segers; Scott R Akers; Raymond R Townsend; Payman Zamani
Journal:  J Am Heart Assoc       Date:  2019-02-19       Impact factor: 5.501

9.  Differential left ventricular and left atrial remodelling in heart failure with preserved ejection fraction patients with and without diabetes.

Authors:  Gaurav S Gulsin; Prathap Kanagala; Daniel C S Chan; Adrian S H Cheng; Lavanya Athithan; Matthew P M Graham-Brown; Anvesha Singh; Jing Yang; Zhuyin Li; Kamlesh Khunti; Melanie J Davies; Jayanth R Arnold; Iain B Squire; Leong L Ng; Gerry P McCann
Journal:  Ther Adv Endocrinol Metab       Date:  2019-07-05       Impact factor: 3.565

10.  Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry.

Authors:  Jasper Tromp; Wan Ting Tay; Wouter Ouwerkerk; Tiew-Hwa Katherine Teng; Jonathan Yap; Michael R MacDonald; Kirsten Leineweber; John J V McMurray; Michael R Zile; Inder S Anand; A Mark Richards; Carolyn S P Lam
Journal:  PLoS Med       Date:  2018-03-27       Impact factor: 11.069

View more
  4 in total

Review 1.  The effect of obesity, hypertension, diabetes mellitus, alcohol, and sleep apnea on the risk of atrial fibrillation.

Authors:  Z Čarná; P Osmančík
Journal:  Physiol Res       Date:  2021-12-30       Impact factor: 2.139

2.  Low Carbohydrate Diets for Diabetic Cardiomyopathy: A Hypothesis.

Authors:  Sabine Kleissl-Muir; Bodil Rasmussen; Alice Owen; Caryn Zinn; Andrea Driscoll
Journal:  Front Nutr       Date:  2022-04-20

3.  Accelerated in Vivo Cardiac Diffusion-Tensor MRI Using Residual Deep Learning-based Denoising in Participants with Obesity.

Authors:  Kellie Phipps; Maaike van de Boomen; Robert Eder; Sam Allen Michelhaugh; Aferdita Spahillari; Joan Kim; Shestruma Parajuli; Timothy G Reese; Choukri Mekkaoui; Saumya Das; Denise Gee; Ravi Shah; David E Sosnovik; Christopher Nguyen
Journal:  Radiol Cardiothorac Imaging       Date:  2021-06-24

Review 4.  Therapeutic and diagnostic targeting of fibrosis in metabolic, proliferative and viral disorders.

Authors:  Alexandros Marios Sofias; Federica De Lorenzi; Quim Peña; Armin Azadkhah Shalmani; Mihael Vucur; Jiong-Wei Wang; Fabian Kiessling; Yang Shi; Lorena Consolino; Gert Storm; Twan Lammers
Journal:  Adv Drug Deliv Rev       Date:  2021-06-15       Impact factor: 15.470

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.